Skip to main content

Table 4 Comparison between PsA patients and controls: change in bodyweight, BMI, CRP and urate at the 6-months (M6) and 12-months (M12) visits

From: Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up

  Patients
N = 39
Controls
N = 39
p-value
M6
Weight loss since baseline. kg 19.0 (15.6–27.0) 23.0 (17.5–29.5) 0.280
Weight loss/baseline weight % 18.7 (15.2–26.7) 21.7 (15.5–26.4) 0.600
∆ BMI kg/m2 7.1 (5.3–9.6] 8.0 (6.3–10.7) 0.213
∆ CRP mg/L 1 (1–4) 2 (0–3) 0.562
∆ urate μmol/L 40 (−2.0–81.5) 40.5 (6.8–77.5) 0.954
M12
Weight loss since baseline, kg 16.1 (10.5–22.8) 16.6 (9.7–22.9) 0.885
Weight loss/baseline weight % 16.3 (10.5–22.4) 15.7 (9.8–21.2) 0.853
∆BMI kg/m2 5.7 (3.6–8.5) 6.0 (3.7–8.2) 0.657
∆ CRP mg/L 2 (0–4) 2 (0–3) 0.952
∆ urate μmol/L 28 (−6.5–68.5) 35.5 (−3.3–58.8) 0.775
  1. BMI = Body Mass Index, CRP = C- reactive protein